Literature DB >> 25575695

Postnatal interleukin-1β administration after experimental prolonged febrile seizures enhances epileptogenesis in adulthood.

Mitsumasa Fukuda1, Masanori Ito, Yoshiaki Yano, Hisaaki Takahashi, Ryota Motoie, Akiko Yano, Yuka Suzuki, Eiichi Ishii.   

Abstract

It remains unclear whether prolonged febrile seizures (pFS) in childhood facilitate mesial temporal lobe epilepsy (MTLE) in adulthood. Interleukin (IL)-1β is associated with seizures in children and immature animal models. Here, we use a rat model of pFS to study the effects of IL-1β on adult epileptogenesis, hippocampal damage, and cognition. We produced prolonged hyperthermia-induced seizures on postnatal days (P) 10-11 and administered IL-1β or saline intranasally immediately after the seizures. Motor and cognitive functions were assessed at P85 using rotarod and passive avoidance tests. Electroencephalogram recordings were conducted at P90 and P120. Hippocampal CA1 and CA3 neurons and gliosis were quantified at the end of the experiment. Spontaneous seizure incidence was significantly greater in rats that had received IL-1β than in those that had received saline or those without hyperthermia-induced seizures (p < 0.05). Seizure frequency did not differ significantly between the three groups and no motor deficits were observed. Passive avoidance learning was impaired in rats that received IL-1β compared with controls (p < 0.05), but was not different from that in rats that received saline. Hippocampal cell numbers and gliosis did not differ between the three groups. These results indicate that neuronal loss and gliosis are not prerequisites for the epileptogenic process that follows pFS. Our results suggest that infantile pFS combined with IL-1β overproduction can enhance adulthood epileptogenesis, and might contribute to the development of MTLE.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25575695     DOI: 10.1007/s11011-014-9648-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  30 in total

1.  Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy.

Authors:  Ahmed Omran; Jing Peng; Ciliu Zhang; Qiu-Lian Xiang; Jinfeng Xue; Na Gan; Huimin Kong; Fei Yin
Journal:  Epilepsia       Date:  2012-06-18       Impact factor: 5.864

2.  Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study.

Authors:  Darrell V Lewis; Shlomo Shinnar; Dale C Hesdorffer; Emilia Bagiella; Jacqueline A Bello; Stephen Chan; Yuan Xu; James MacFall; William A Gomes; Solomon L Moshé; Gary W Mathern; John M Pellock; Douglas R Nordli; L Matthew Frank; James Provenzale; Ruth C Shinnar; Leon G Epstein; David Masur; Claire Litherland; Shumei Sun
Journal:  Ann Neurol       Date:  2014-03-01       Impact factor: 10.422

3.  Exposure to prenatal stress enhances the development of seizures in young rats.

Authors:  Lihle Qulu; Willie M U Daniels; Musa V Mabandla
Journal:  Metab Brain Dis       Date:  2012-04-17       Impact factor: 3.584

4.  Genetic susceptibility to simple febrile seizures: interleukin-1beta promoter polymorphisms are associated with sporadic cases.

Authors:  Ryutaro Kira; Hiroyuki Torisu; Megumi Takemoto; Akihiko Nomura; Yasunari Sakai; Masafumi Sanefuji; Kanji Sakamoto; Shigetaka Matsumoto; Kenjiro Gondo; Toshiro Hara
Journal:  Neurosci Lett       Date:  2005-08-26       Impact factor: 3.046

5.  Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.

Authors:  Paula A Garay; Elaine Y Hsiao; Paul H Patterson; A K McAllister
Journal:  Brain Behav Immun       Date:  2012-07-25       Impact factor: 7.217

6.  Postnatal inflammation increases seizure susceptibility in adult rats.

Authors:  Michael A Galic; Kiarash Riazi; James G Heida; Abdeslam Mouihate; Neil M Fournier; Sarah J Spencer; Lisa E Kalynchuk; G Campbell Teskey; Quentin J Pittman
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

7.  Interleukin-1beta enhances susceptibility to hyperthermia-induced seizures in developing rats.

Authors:  Mitsumasa Fukuda; Yuka Suzuki; Yoshito Ishizaki; Ryutaro Kira; Chiya Kikuchi; Shohei Watanabe; Hitomi Hino; Takehiko Morimoto; Toshiro Hara; Eiichi Ishii
Journal:  Seizure       Date:  2008-11-11       Impact factor: 3.184

8.  Maternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain.

Authors:  Géraldine Arrode-Brusés; Juan L Brusés
Journal:  J Neuroinflammation       Date:  2012-04-30       Impact factor: 8.322

9.  A new clinico-pathological classification system for mesial temporal sclerosis.

Authors:  Ingmar Blümcke; Elisabeth Pauli; Hans Clusmann; Johannes Schramm; Albert Becker; Christian Elger; Martin Merschhemke; Heinz-Joachim Meencke; Thomas Lehmann; Andreas von Deimling; Christian Scheiwe; Josef Zentner; Benedikt Volk; Johann Romstöck; Hermann Stefan; Michelle Hildebrandt
Journal:  Acta Neuropathol       Date:  2007-01-13       Impact factor: 17.088

10.  Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production.

Authors:  Teresa Ravizza; Francesco Noé; Daniela Zardoni; Valentina Vaghi; Marco Sifringer; Annamaria Vezzani
Journal:  Neurobiol Dis       Date:  2008-05-29       Impact factor: 5.996

View more
  2 in total

1.  High mobility group box 1 enhances hyperthermia-induced seizures and secondary epilepsy associated with prolonged hyperthermia-induced seizures in developing rats.

Authors:  Masanori Ito; Hisaaki Takahashi; Hajime Yano; Yusuke I Shimizu; Yoshiaki Yano; Yoshito Ishizaki; Junya Tanaka; Eiichi Ishii; Mitsumasa Fukuda
Journal:  Metab Brain Dis       Date:  2017-09-06       Impact factor: 3.584

2.  Chronic Trigeminal Nerve Stimulation Protects Against Seizures, Cognitive Impairments, Hippocampal Apoptosis, and Inflammatory Responses in Epileptic Rats.

Authors:  Qian-Qian Wang; Li-Jun Zhu; Xian-Hong Wang; Jian Zuo; Hui-Yan He; Miao-Miao Tian; Lei Wang; Gui-Ling Liang; Yu Wang
Journal:  J Mol Neurosci       Date:  2016-03-14       Impact factor: 3.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.